Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNASeq analysis of CC011, CC074, Trimko, and Trim wt female mice on 3dpi and 6dpi after infection with Ebola virus

ABSTRACT: Gene expression changes in the liver was studied by RNAseq Results: Strong differences in the liver-specific responses between CC011 and CC074 mice

ORGANISM(S): Mus musculus

PROVIDER: GSE262041 | GEO | 2024/04/17

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNAseq analysis of CC F2 female mice after infection with Ebola virus

Project description:Gene expression changes in the liver was studied by RNAseq Results: Strong differences in the immune response between mice with high body weight loss and mice with moderate body weight loss

2022-08-31 | GSE165142 | GEO

RNAseq analysis of CC F2 female mice at day3 after infection with Ebola virus

Project description:F2 female mice were generated from a cross of two collaborative cross (CC) strains, CC011 x CC074. These mice were infected with Ebola virus and liver samples were prepared at day three after infection. RNA from the livers were prepared and subjected to RNAseq analysis. This data set can be combined with data from GSE165142, in which female mice from the same cross were infected with Ebola virus, and liver samples were prepared at day six after infection. Results: Variations in gene expression levels that may be perdictive for severity

2022-08-31 | GSE173914 | GEO

RNASeq analysis of CC011, CC074, Trimko, and Trim wt female mice on 3dpi and 6dpi after infection with Ebola virus

Project description:RNASeq analysis of CC011, CC074, Trimko, and Trim wt female mice on 3dpi and 6dpi after infection with Ebola virus

| PRJNA1090082 | ENA

RNAseq analysis of CC F2 female mice after infection with Ebola virus

Project description:RNAseq analysis of CC F2 female mice after infection with Ebola virus

| PRJNA693338 | ENA

RNAseq analysis of CC F2 female mice at day3 after infection with Ebola virus

Project description:RNAseq analysis of CC F2 female mice at day3 after infection with Ebola virus

| PRJNA727545 | ENA

Bombali virus infection of cynomolgus macaques as a survival model of Ebola virus disease

Project description:Ebolaviruses are a genus of emerging RNA viruses of which multiple species are known to cause severe disease and multiple outbreaks in humans. The most recently discovered ebolavirus species, Bombali virus (BOMV), was detected via metagenomic surveillance of bats in Sierra Leone. Additional surveillance detected BOMV in bats from Kenya, Guinea, Mozambique, and Tanzania. Infectious BOMV isolation from field samples has been unsuccessful; however, a recombinant BOMV (rBOMV) has been recovered via reverse genetics. While rBOMV has been used to challenge IFNAR-/- and humanized mice, it has yet to be characterized in a nonhuman primate (NHP) model, which is the gold-standard model for Ebola virus disease (EVD). We challenged eight macaques were challenged intramuscularly with 1000 PFU of rBOMV. Four macaques survived to the predetermined natural history study endpoint (28 DPI), and four were sacrificed at 7 DPI to characterize the disease pathology. NHPs sacrificed at 7 DPI had clear involvement in target organs of ebolavirus replication. Antigen-positive mononuclear cells were present in multiple tissues including the liver (Kupffer cells), lymph nodes, and adrenal gland. NHPs in the natural history study developed classic signs of EVD including coagulopathy with thrombocytopenia, lymphopenia, neutrophilia, and elevated inflammation markers. Disease signs correlated with viremia with onset at ~7 DPI and resolution by 15-21 DPI. BOMV-challenged NHPs developed a robust adaptive immune response, with strong BOMV-specific IgG and neutralizing titers by study endpoint at 28 DPI. This combination of Ebola-like yet nonlethal disease makes rBOMV challenge of cynomolgus macaques an attractive survival model of EVD.

2026-01-06 | GSE290671 | GEO

RNAseq analysis of BXD mouse strains infected with PR8M virus

Project description:Gene expression changes in the lung was studied by RNAseq Results: Strong differences in the host response between strains

2021-01-29 | GSE165744 | GEO

RNAseq analysis of CC strains after influenza A virus infection identifies genetic control of the host response

Project description:Gene expression changes in the lung was studied by RNAseq in different CC mouse strains infected with influenza A virus. Results: Strong differences between the genetically CC mouse strains can be observed in the activation of host defense genes. These differences can be related to genetic variants in the genome of the CC strains. Furthermore, different strains exhibit variant susceptibility to infections (body weight loss and survival). These differences can be correlated to differences in gene expression profiles.

2020-07-08 | GSE136748 | GEO

whole liver RNAseq

Project description:whole liver RNAseq

| PRJNA1168971 | ENA

Plasma proteomic, human Ebola virus disease

Project description:The 2013-2016 Ebola Zaire virus (EBV) outbreak in West Africa resulted in over 28,000 cases and 11,000 deaths. Ebola virus disease (EVD) is a highly virulent systemic disease with a high case fatality rate of ~ 50%. EVD results in hemorrhagic fever marked by an exaggerated systemic inflammatory response, and impaired vascular and coagulation systems. The immune response of patients who either survived or died is characterized by strong differences. Notably, fatalities showed a diminished capacity to mount an appropriate immune response, resulting in high viremia and increased pro-inflammatory cytokine production. In this study, we analyzed 38 sequential samples collected from 12 patients: 8 survivors and 4 fatalities. Our analytical strategy combined three protein-based platforms covering three different fractions of the plasma proteome: the undepleted classical plasma proteome, the depleted plasma proteome, and cytokines/chemokines, using LC/MS- and antibody-based assays, resulting in over 1000 quantified host and pathogen proteins. For depletion of the most abundant plasma proteins, we advanced a perchloric acid-based precipitation method. This method is low cost, high-throughput and robust.

2022-03-29 | PXD030260 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data